155 related articles for article (PubMed ID: 23748811)
1. Sorafenib acts synergistically in combination with radiotherapy without causing intestinal damage in colorectal cancer.
Jeong YK; Kim MS; Lee JY; Kim EH; Kim W; Ha H; Jeong JH
Tumori; 2013; 99(2):176-82. PubMed ID: 23748811
[TBL] [Abstract][Full Text] [Related]
2. The mechanisms responsible for the radiosensitizing effects of sorafenib on colon cancer cells.
Kim EH; Kim MS; Jung WG
Oncol Rep; 2014 Dec; 32(6):2421-8. PubMed ID: 25242034
[TBL] [Abstract][Full Text] [Related]
3. Sorafenib modulates the radio sensitivity of hepatocellular carcinoma cells in vitro in a schedule-dependent manner.
Li Q; Hu Y; Xi M; He L; Zhao L; Liu M
BMC Cancer; 2012 Oct; 12():485. PubMed ID: 23088517
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of SU5416, an inhibitor of vascular endothelial growth factor receptor, as a radiosensitizer for colon cancer cells.
Kim EH; Lee H; Jeong YK; Jung WG
Oncol Rep; 2016 Aug; 36(2):763-70. PubMed ID: 27373272
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of enhancement of radiation-induced cytotoxicity by sorafenib in colorectal cancer.
Kim YB; Jeung HC; Jeong I; Lee K; Rha SY; Chung HC; Kim GE
J Radiat Res; 2013 Jan; 54(1):52-60. PubMed ID: 22923745
[TBL] [Abstract][Full Text] [Related]
6. Effect of sorafenib on cisplatin-based chemoradiation in head and neck cancer cells.
Möckelmann N; Rieckmann T; Busch CJ; Becker B; Gleißner L; Hoffer K; Omniczynski M; Steinmeister L; Laban S; Grénman R; Petersen C; Rothkamm K; Dikomey E; Knecht R; Kriegs M
Oncotarget; 2016 Apr; 7(17):23542-51. PubMed ID: 27015558
[TBL] [Abstract][Full Text] [Related]
7. Sorafenib and radiation: a promising combination in colorectal cancer.
Suen AW; Galoforo S; Marples B; McGonagle M; Downing L; Martinez AA; Robertson JM; Wilson GD
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):213-20. PubMed ID: 20708486
[TBL] [Abstract][Full Text] [Related]
8. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
[TBL] [Abstract][Full Text] [Related]
9. Sorafenib sensitizes human colorectal carcinoma to radiation via suppression of NF-κB expression in vitro and in vivo.
Kuo YC; Lin WC; Chiang IT; Chang YF; Chen CW; Su SH; Chen CL; Hwang JJ
Biomed Pharmacother; 2012 Feb; 66(1):12-20. PubMed ID: 22265104
[TBL] [Abstract][Full Text] [Related]
10. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
Huang CY; Tai WT; Hsieh CY; Hsu WM; Lai YJ; Chen LJ; Shiau CW; Chen KF
Cancer Lett; 2014 Jul; 349(2):136-43. PubMed ID: 24735751
[TBL] [Abstract][Full Text] [Related]
11. Combination effect of cetuximab with radiation in colorectal cancer cells.
Shin HK; Kim MS; Lee JK; Lee SS; Ji YH; Kim JI; Jeong JH
Tumori; 2010; 96(5):713-20. PubMed ID: 21302618
[TBL] [Abstract][Full Text] [Related]
12. Radiosensitivity enhancement of human hepatocellular carcinoma cell line SMMC-7721 by sorafenib through the MEK/ERK signal pathway.
Dai XF; Ding J; Zhang RG; Ren JH; Ma CM; Wu G
Int J Radiat Biol; 2013 Sep; 89(9):724-31. PubMed ID: 23682582
[TBL] [Abstract][Full Text] [Related]
13. Sorafenib potentiates irradiation effect in hepatocellular carcinoma in vitro and in vivo.
Yu W; Gu K; Yu Z; Yuan D; He M; Ma N; Lai S; Zhao J; Ren Z; Zhang X; Shao C; Jiang GL
Cancer Lett; 2013 Feb; 329(1):109-17. PubMed ID: 23142289
[TBL] [Abstract][Full Text] [Related]
14. Single-agent therapy with sorafenib or 5-FU is equally effective in human colorectal cancer xenograft--no benefit of combination therapy.
Wehler TC; Hamdi S; Maderer A; Graf C; Gockel I; Schmidtmann I; Hainz M; Berger MR; Theobald M; Galle PR; Moehler M; Schimanski CC
Int J Colorectal Dis; 2013 Mar; 28(3):385-98. PubMed ID: 22983756
[TBL] [Abstract][Full Text] [Related]
15. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
[TBL] [Abstract][Full Text] [Related]
16. Metformin Radiosensitizes p53-Deficient Colorectal Cancer Cells through Induction of G2/M Arrest and Inhibition of DNA Repair Proteins.
Jeong YK; Kim MS; Lee JY; Kim EH; Ha H
PLoS One; 2015; 10(11):e0143596. PubMed ID: 26599019
[TBL] [Abstract][Full Text] [Related]
17. The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer.
He S; Smith DL; Sequeira M; Sang J; Bates RC; Proia DA
Invest New Drugs; 2014 Aug; 32(4):577-86. PubMed ID: 24682747
[TBL] [Abstract][Full Text] [Related]
18. Combination effect of epigenetic regulation and ionizing radiation in colorectal cancer cells.
Kim JG; Bae JH; Kim JA; Heo K; Yang K; Yi JM
PLoS One; 2014; 9(8):e105405. PubMed ID: 25136811
[TBL] [Abstract][Full Text] [Related]
19. Synergistic effect of sorafenib with ionizing radiation on human oral cancer cells.
Hsu FT; Chang B; Chiang IT; Wu TH; Hwang JJ
In Vivo; 2014; 28(5):925-33. PubMed ID: 25189909
[TBL] [Abstract][Full Text] [Related]
20. Icotinib hydrochloride enhances the effect of radiotherapy by affecting DNA repair in colorectal cancer cells.
Ma H; Bi J; Liu T; Ke Y; Zhang S; Zhang T
Oncol Rep; 2015 Mar; 33(3):1161-70. PubMed ID: 25572529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
